Hospital Ramón y Cajal -ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2016

  1. Therapeutic targets and investigated treatment strategies in Acanthamoeba keratitis

    Expert Opinion on Orphan Drugs, Vol. 4, Núm. 10, pp. 1069-1073

2014

  1. Influence of Acanthamoeba genotype on clinical course and outcomes for patients with Acanthamoeba keratitis in Spain

    Journal of Clinical Microbiology, Vol. 52, Núm. 4, pp. 1213-1216

2013

  1. Acanthamoeba keratitis: An emerging disease gathering importance worldwide?

    Trends in Parasitology, Vol. 29, Núm. 4, pp. 181-187

  2. Co-isolation of Vahlkampfia and acanthamoeba in acanthamoeba-like keratitis in a Spanish population

    Cornea, Vol. 32, Núm. 5, pp. 608-614

  3. Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 251, Núm. 9, pp. 2111-2117

  4. Scleral and intraocular amoebic dissemination in Acanthamoeba keratitis

    Cornea, Vol. 32, Núm. 12, pp. 1625-1627

2012

  1. Successful monitoring and treatment of intraocular dissemination of Acanthamoeba

    Archives of Ophthalmology

2011

  1. Acanthamoeba keratitis due to genotype T11 in a rigid gas permeable contact lens wearer in Spain

    Contact Lens and Anterior Eye, Vol. 34, Núm. 2, pp. 83-86

  2. Corrigendum to "Acanthamoeba keratitis due to genotype T11 in a rigid gas permeable contact lens wearer in Spain" [Contact Lens Ant. Eye 34 (2) (2011) 83-86]

    Contact Lens and Anterior Eye